Trial NCT01351038

View at ClinicalTrials.gov 
Org. Study IDs: AGMT Gastric-4

Last trial update was posted on 2013-06-04

MeSH Interventions

Capecitabine Epirubicin Oxaliplatin Panitumumab

MeSH Conditions

Adenocarcinoma

Other Conditions

KRAS Wild Type Resectable Type II Gastric Adenocarcinoma

Stopping Reasons

REAL trial showed a significant difference in OS for reduced EOX and standard EOX

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID